Medical tech firm Medipattern gets FDA nod for breast cancer detection software

TORONTO (CP) - Medipattern Corp.'s breast cancer detection software has received a nod from the United States Food and Drug Administration and is expected be commercially available in the U.S. this summer, the company said Thursday. ...More